Hot line:010-83057670
EN-
082021-09Blockbuster News | The Kick-off Meeting of the World's First Clinical Trial Research Center for Stem Cell Innovative Drugs for Ulcerative Colitis was Successfully Held
On September 7, the kick-off meeting of the Clinical Trial Research Center of Human Umbilical Cord Mesenchymal Stem Cell Injection for Patients with Moderate and Severe Ulcerative Colitis was successfully held in the form of cloud video. -
062021-09Over 50 New Colleagues Joined in Leadingpharm CXO System, which has Officially Entered the Era of Accelerated Development of 2.0!
On September 6, Leadingpharm CXO Platform ushered in a new group of more than 50 new colleagues, injecting new development vitality into Lifezhengzhou Biomedical Park. -
262021-08Strategic Cooperation | Leadingpharm has Reached Strategic Cooperation with DASAN Pharmaceutical (Korea)
On August 26, the strategic signing ceremony between Beijing Leadingpharm Medical and Dashan Pharmaceutical was held in Research Institute of Leadingpharm in Beijing. -
242021-08The Biomedicine Integrated R & D Service Base of Beijing Leadingpharm has Landed in Yongchuan, Chongqing
On August 23, the Smart China EXPO 2021 Key Projects of Investment Promotion and Signing Activities of Major Projects Signing Ceremony was held in Chongqing Yuelai International Convention Center. -
282021-07Leadingpharm and China Biology Signed an Agreement of Phase-I Clinical Research on a New Drug for Type 2 Diabetes
Recently, Leadingpharm signed a cooperation agreement with China Biology on the phase I clinical research project of "insulin secreting peptide fusion protein injection". The project is developed by Lanzhou Institute of biological products of China Biology.
010-83057670
Address：
Marketing Department：
Leadingpharm
Pharm News
010-61006450
